CoChat

A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major Depression

Open access
Tollefson, Gary D., Bosomworth, Janet C., Heiligenstein, John H., Potvin, Janet H., Holman, Susan · 1995 · International Psychogeriatrics
Cited by 142

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Depression in the geriatric population is a frequent, serious, and potentially reversible disorder, yet relatively few blinded, controlled, antidepressant trials have been reported. A number of age related issues complicate safe and effective pharmacotherapy. In a 6-week, double-blind trial in moderately to severely depressed (nonpsychotic) outpatients over age 60, fluoxetine (N = 335) was statistically significantly more efficacious than placebo (N = 336) in overall response (43.9% vs. 31.6%, p = .002) and remission (31.6% vs. 18.6%, p < .001) rates. Analyses of early discontinuations because of an adverse drug event revealed no statistically significantly greater rate with fluoxetine (n = 39; 11.6) than was seen with placebo (n = 29; 8.6%). These results corroborate that major depression in an older population is responsive to antidepressant pharmacotherapy. Specifically, fluoxetine, at a conventional 20-mg dose, was both safe and effective relative to placebo in this special population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1041610295001888

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 28

  1. Avom, 1989, Use of psychoactive medication and the quality of care in rest homes: Findings and policy implications of a statewide study, New England Journal of Medicine, 320, 227, 10.1056/NEJM198901263200406 · DOI · Paper page
  2. Blazer, 1989, Epidemiology of “depression” in later life, Journal ofGeriatric Psychiatry and Neurology, 22, 35
  3. Blazer, 1987, The epidemiology of depression in an elderly community population, Gerontologist, 27, 281, 10.1093/geront/27.3.281 · DOI · Paper page
  4. Borson, 1986, Symptomatic depression in elderly medical outpatients. 1. Prevalence, demography, and health-service utilization, Journal of the American Geriatrics Society, 34, 341, 10.1111/j.1532-5415.1986.tb04316.x · DOI · Paper page
  5. Brink, 1982, Screening tests for geriatric depression, Clinical Gerontology, 1, 37, 10.1300/J018v01n01_06 · DOI · Paper page
  6. Cohn, 1990, Double-blind comparison of sertraline and amitriptyline in elderly depressed patients, Journal of Clinical Psychiatry, 57, 28
  7. Conover, 1981, Rank transformations as a bridge between parametric and nonparametric statistics, American Statistician, 34, 124, 10.1080/00031305.1981.10479327 · DOI · Paper page
  8. Dunner, 1992, Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression, Journal of Clinical Psychiatry, 53, 57
  9. Falk, 1989, Fluoxetine versus trazodone in depressed geriatric patients, Journal of Geriatric Psychiatry and Neurology, 2, 208, 10.1177/089198878900200407 · DOI
  10. Fava, 1992, High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine, Journal of Affective Disorders, 25, 229, 10.1016/0165-0327(92)90080-P · DOI
  11. Feighner, 1985, Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder, Journal of Clinical Psychiatry, 46, 20
  12. Folstein, 1975, Mini Mental State: A practical method for grading the cognitive state of patients for the clinician, Journal of Psychiatric Research, 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  13. Georgotas, 1989, The additional benefit of extending an antidepressant trial past seven weeks in the depressed elderly, International Journal of Geriatric Psychiatry, 4, 191, 10.1002/gps.930040403 · DOI
  14. Gershon, 1988, Antidepressant drug studies, 1964 to 1986: Empirical evidence for aging patients, Journal of Clinical Psychopharmacology, 8, 311
  15. Gottfries, 1982, A new rating scale for dementia syndromes, Archives of Gerontology Geriatrics, 1, 311, 10.1016/0167-4943(82)90031-0 · DOI · Paper page
  16. Gurland, 1988, Depression and disability in the elderly: Reciprocal relations and changes with age, International Journal of Geriatric Psychiatry, 3, 163, 10.1002/gps.930030304 · DOI · Paper page
  17. Hamilton, 1960, A rating scale for depression, Journal ofNeurology, Neurosurgery and Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  18. Hendrie, 1990, An overview of depression in the elderly, Psychiatric Annals, 20, 64, 10.3928/0048-5713-19900201-05 · DOI
  19. Keller, 1981, Major depressive disorder Initial results from aone- year prospective naturalistic follow-up study, Journal of Nervous and Mental Disease, 169, 761, 10.1097/00005053-198112000-00003 · DOI
  20. Pande, 1993, Severity of depression and response to fluoxetine, International Clinical Psychopharmacology, 8, 243, 10.1097/00004850-199300840-00006 · DOI · Paper page
  21. Post, 1972, The management and nature of depressive illness in late life: A follow- through study, British Journal of Psychiatry, 121, 393, 10.1192/bjp.121.4.393 · DOI · Paper page
  22. Regier, 1984, The NIMH epidemiologic catchment area program: Historical context, major objectives, and study population characteristics, Archives of General Psychiatry, 41, 934, 10.1001/archpsyc.1984.01790210016003 · DOI · Paper page
  23. Reynolds, 1992, Treatment of depression in special populations, Journal of Clinical Psychiatry, 53, 45
  24. Schweizer, 1990, What constitutes an adequate antidepressant trial for fluoxetine?, Journal of Clinical Psychiatry, 57, 8
  25. Shamoian, 1985, Assessing depression in elderly patients, Hospital and Community Psychiatry, 36, 338
  26. Shapiro, 1984, Utilization of health and mental-health services: 3 epidemiologic catchment-area sites, Archives of General Psychiatry, 41, 971, 10.1001/archpsyc.1984.01790210053007 · DOI · Paper page
  27. Wakelin, 1986, Fluvoxamine in the treatment of the older depressed patient; doubleblind, placebo-controlled data, International Clinical Psychopharmacology, 1, 221, 10.1097/00004850-198607000-00005 · DOI
  28. Wernicke, 1987, Fixed-dose fluoxetine therapy for depression, Psychopharmacology Bulletin, 23, 164

Cited by

See all 142

Metadata

Authors
Tollefson, G. D., Bosomworth, J. C., Heiligenstein, J. H., Potvin, J. H., & Holman, S.
Venue
International Psychogeriatrics
Publisher
Elsevier BV
Published
1995-03
Volume
7
Issue
1
Pages
89-104
ISSN
1041-6102 (ISSN-L)
OpenAlex
W2160008980
Cited by
142
References
1
FWCI
5.18
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major Depression. https://app.cochat.ai/papers/10.1017/s1041610295001888
The paper
Tollefson, G. D., Bosomworth, J. C., Heiligenstein, J. H., Potvin, J. H., & Holman, S. (1995). A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major Depression. International Psychogeriatrics. https://doi.org/10.1017/s1041610295001888

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.